COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database

Atrial fibrillation (AF) has been described in COVID-19 patients. Recently, some case reports and US pharmacovigilance analyses described AF onset as a rare adverse event following COVID-19 vaccination. The possible correlation is unclear. We systematically analyzed the reports of AF related to COVI...

Full description

Bibliographic Details
Main Authors: Rosanna Ruggiero, Maria Donniacuo, Annamaria Mascolo, Mario Gaio, Donato Cappetta, Concetta Rafaniello, Giovanni Docimo, Consiglia Riccardi, Imma Izzo, Donatella Ruggiero, Giuseppe Paolisso, Francesco Rossi, Antonella De Angelis, Annalisa Capuano
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
atrial fibrillation
adverse events following immunization
COVID-19 vaccines
post-marketing surveillance
EudraVigilance
cardiac safety
Online Access:https://www.mdpi.com/2227-9059/11/6/1584

Internet

https://www.mdpi.com/2227-9059/11/6/1584

Similar Items